Innocan Pharma Announces Offering of a Debenture to its Largest Shareholder, Tamar Innovest
PR Newswire —
HERZLIYA, Israel and CALGARY, AB, March 11, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it intends to complete an offering of a debenture of the Company (the "Debenture") to its largest...